Detalhe da pesquisa
1.
Guidelines for the development of a critical software under emergency.
Inf Softw Technol
; 152: 107061, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093290
2.
Role of neutral ceramidase in colon cancer.
FASEB J
; 30(12): 4159-4171, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609772
3.
Effect of sphingosine kinase 1 inhibition on blood pressure.
FASEB J
; 27(2): 656-64, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23109673
4.
Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins.
Biochem J
; 449(3): 661-72, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23106337
5.
Protein tyrosine nitration and thiol oxidation by peroxynitrite-strategies to prevent these oxidative modifications.
Int J Mol Sci
; 14(4): 7542-70, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23567270
6.
Direct measurement of adhesion force between a yeast cell and a lactic acid bacterium cell with atomic force microscopy.
J Biosci Bioeng
; 133(2): 155-160, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863625
7.
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells.
Front Immunol
; 13: 997482, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172388
8.
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells.
Stem Cell Rev Rep
; 17(2): 652-661, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33410096
9.
Two pathways for cyclooxygenase-2 protein degradation in vivo.
J Biol Chem
; 284(45): 30742-53, 2009 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19758985
10.
Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies.
Stem Cell Rev Rep
; 16(2): 369-384, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32008159
11.
Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy.
Stem Cell Rev Rep
; 16(2): 385-396, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31970687
12.
Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.
Prog Lipid Res
; 46(2): 108-25, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17316818
13.
Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch.
Stem Cell Rev Rep
; 15(3): 443-447, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826931
14.
Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells.
J Cancer
; 10(18): 4408-4419, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413761
15.
Anti-CD19 chimeric antigen receptor targeting of CD19â¯+â¯acute myeloid leukemia.
Leuk Res Rep
; 9: 42-44, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892548
16.
Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia.
Leukemia
; 32(6): 1317-1326, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29515236
17.
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.
Oncotarget
; 8(68): 112783-112796, 2017 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348865
18.
Effect of Serum Cholesterol on Insulin Secretory Capacity: Shimane CoHRE Study.
PLoS One
; 11(2): e0149452, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26881755
19.
Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.
Oncotarget
; 7(35): 56219-56232, 2016 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27494836
20.
Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR.
Stem Cell Rev Rep
; 17(6): 2120-2123, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458965